查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683379

全球復健机器人外骨骼市场 - 2025 至 2033 年

Global Robotic Exoskeletons for Rehabilitation Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球復健机器人外骨骼市场规模达 4.28 亿美元，预计到 2033 年将达到 12.37 亿美元，2025-2033 年预测期内的复合年增长率为 12.5%。

復健用机器人外骨骼是一种穿戴式设备，可帮助患有行动不便问题的人，例如脊髓损伤、中风或神经系统疾病引起的行动不便的人。这些设备具有轻质的框架，可围绕使用者的身体，并包含马达、感测器和执行器以协助运动，尤其是步行。它们支撑使用者的身体，使患者能够参与復健锻炼，提高行走能力并在日常生活中获得独立性。

市场动态：

驱动因素与约束因素

肌肉骨骼疾病盛行率不断上升

肌肉骨骼疾病的盛行率不断上升，预计将大大推动机器人外骨骼在復健市场的发展。肌肉骨骼疾病，包括脊髓损伤、中风和神经系统疾病，通常会导致行动能力受损，因此復原对于復原至关重要。患有肌肉骨骼疾病的人数正在增加。

例如，根据美国国立卫生研究院 2023 年的报告，约有 17.1 亿人患有肌肉骨骼疾病。随着全球人口老化和这些疾病的发生率上升，对机器人外骨骼等先进復健解决方案的需求也随之增加。

个人化復健治疗的需求日益增长，以及对更有效的恢復选择的渴望进一步推动了机器人外骨骼的采用。随着越来越多的患者寻求肌肉骨骼损伤的创新解决方案，机器人外骨骼提供了恢復功能和独立性的有效方法，推动了市场的成长。

严格的监管框架

机器人外骨骼的高成本可能会严重限制这些设备復健市场的成长。这些外骨骼采用了先进的技术、专门的材料和复杂的工程，所有这些都增加了生产和购买成本。此外，维护设备和培训医疗保健提供者使用这些设备的费用可能会成为许多医院和復健中心的障碍，特别是在医疗保健预算有限的地区。因此，机器人外骨骼的高昂价格可能会阻碍其广泛采用和使用。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 按患者类型分类的片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 肌肉骨骼疾病盛行率不断上升
      • 不断进步的技术
    • 限制
      • 机器人外骨骼成本高昂
      • 缺乏意识
    • 机会
      • 扩充应用
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：復健机器人外骨骼市场（按类型）

  • 下肢外骨骼
  • 上身外骨骼
  • 全身外骨骼

第 6 章：復健市场机器人外骨骼（依患者类型）

  • 已停用
  • 儿科
  • 老年

第 7 章：復健机器人外骨骼市场（按应用）

  • 神经復健
  • 脊髓损伤康復
  • 骨科復健
  • 其他的

第 8 章：復健机器人外骨骼市场（依最终用户划分）

  • 復健中心
  • 医院和诊所
  • 孤儿院
  • 居家护理

第 9 章：復健机器人外骨骼市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Cyberdyne Care Robotics GmbH
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • BIONIK
  • ExoAtlet
  • Lifeward, Inc.
  • Gogoa.eu
  • German Bionic Systems GmbH
  • Siyi Intelligent Technology Co., Ltd.
  • Hocoma
  • Rex Bionics Ltd.
  • RoboCT

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD9319

The global robotic exoskeletons for rehabilitation market reached US$ 428 million in 2024 and is expected to reach US$ 1,237 million by 2033, growing at a CAGR of 12.5% during the forecast period 2025-2033.

Robotic exoskeletons for rehabilitation are wearable devices that help people with mobility issues, like those caused by spinal cord injuries, stroke, or neurological conditions. These devices have a lightweight frame that fits around the user's body and includes motors, sensors, and actuators to assist with movement, especially walking. They support the user's body, allowing patients to participate in rehabilitation exercises, improve their walking ability, and gain independence in their daily lives.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Musculoskeletal Disorders

The increasing prevalence of musculoskeletal disorders is expected to significantly drive the robotic exoskeletons for the rehabilitation market. Musculoskeletal conditions, including spinal cord injuries, stroke, and neurological disorders, often result in impaired mobility, making rehabilitation essential for recovery. There is a growing number of individuals suffering from musculoskeletal disorders.

For instance, according to the National Institute of Health in 2023, it is reported that approximately 1.71 billion people are living with a musculoskeletal condition. As the global population ages and the incidence of these disorders rises, the demand for advanced rehabilitation solutions like robotic exoskeletons increases.

The growing need for personalized rehabilitation treatments and the desire for more effective recovery options further boost the adoption of robotic exoskeletons. As more patients seek innovative solutions for musculoskeletal impairments, robotic exoskeletons provide an effective way to restore functionality and independence, driving growth in the market.

Stringent Regulatory Frameworks

The high costs of robotic exoskeletons could significantly limit the growth of the rehabilitation market for these devices. These exoskeletons are made with advanced technology, specialized materials, and intricate engineering, all of which drive up the production and purchase costs. Additionally, the expenses associated with maintaining the devices and training healthcare providers to use them can be barriers for many hospitals and rehabilitation centers, particularly in areas with constrained healthcare budgets. As a result, the steep price of robotic exoskeletons could prevent widespread adoption and use.

Segment Analysis

The global robotic exoskeletons for rehabilitation market is segmented based on the type, patient type, application, end-user and region.

Lower body exoskeletons in the type segment is expected to dominate the robotic exoskeletons for rehabilitation market

The lower body exoskeletons segment is expected to dominate the robotic exoskeletons for the rehabilitation market due to their significant ability to restore mobility and independence for individuals with lower limb impairments. A large number of individuals suffer and experience lower limbs, hip, and knee fractures, which require rehabilitation after a certain period.

For instance, according to a study by the National Institute of Health in 2024, the overall incidence of lower limb fractures was 215.9 lower limb long bone fractures per 100,000 patients per year. These devices, which help patients with conditions like spinal cord injuries, stroke, and neurological disorders regain the ability to walk and perform functional movements, are increasingly seen as essential for rehabilitation.

The growing focus on active rehabilitation over passive treatments is driving adoption, as lower body exoskeletons enable patients to engage in weight-bearing activities such as walking, standing, and even climbing stairs. These activities are vital for improving muscle strength, bone density, and overall recovery.

Additionally, continuous advancements in technology have made these devices more user-friendly, cost-effective, and efficient, further expanding their reach in healthcare settings. As a result, the segment is expected to dominate the market, driven by rising patient demand, clinical benefits, and ongoing technological innovations.

Geographical Analysis

North America is expected to dominate the robotic exoskeletons for rehabilitation market

North America is expected to maintain a dominant position in the robotic exoskeletons for the rehabilitation market, driven by several key factors. The region's advanced healthcare infrastructure plays a crucial role in facilitating the adoption of innovative technologies, such as robotic exoskeletons, particularly in the United States. The country dominates in both the development and implementation of these devices, supported by significant contributions from major companies and research institutions advancing robotic rehabilitation solutions.

Additionally, North America benefits from substantial healthcare expenditure, enabling hospitals and rehabilitation centers to invest in advanced equipment. Well-established health insurance systems that can cover the costs of medical devices, coupled with an increasing focus on rehabilitation therapies for patients with spinal cord injuries, strokes, and other mobility challenges, further support market growth.

Companies in the region are entering into strategic collaborations to expand and innovate advanced robotic exoskeletons for rehabilitation.

For instance, in May 2024, DIH Holding US, Inc. entered a strategic collaboration with B-Temia Inc. to drive AI-based innovation and smart solutions in the rehabilitation industry. This partnership combines B-Temia's expertise in AI-driven robotics with DIH's broad robotic portfolio, marking a significant step in improving functional rehabilitation and support in North America. Thus, the above factors are combinedly driving the region's growth and holding the region in a dominant position.

Competitive Landscape

The global market players in the robotic exoskeletons for rehabilitation market are Cyberdyne Care Robotics GmbH, BIONIK, ExoAtlet, Lifeward, Inc., Gogoa.eu, German Bionic Systems GmbH, Siyi Intelligent Technology Co., Ltd., Hocoma, Rex Bionics Ltd., and RoboCT, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global robotic exoskeletons for rehabilitation market report would provide approximately 45 tables, 46 figures and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Patient Type
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Musculoskeletal Disorders
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs Associated with the Robotic Exoskeletons
      • 3.1.2.2. Lack of Awareness
    • 3.1.3. Opportunity
      • 3.1.3.1. Expanding Applications
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Robotic Exoskeletons for Rehabilitation Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Lower Body Exoskeletons*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Upper Body Exoskeletons
  • 5.4. Full Body Exoskeletons

6. Robotic Exoskeletons for Rehabilitation Market, By Patient Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 6.1.2. Market Attractiveness Index, By Patient Type
  • 6.2. Disabled*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pediatrics
  • 6.4. Elderly

7. Robotic Exoskeletons for Rehabilitation Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Neuro Rehabilitation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Spinal Cord Injury Rehabilitation
  • 7.4. Orthopedic Rehabilitation
  • 7.5. Others

8. Robotic Exoskeletons for Rehabilitation Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Rehabilitation Centers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospitals & Clinics
  • 8.4. Orphanages
  • 8.5. Homecare

9. Robotic Exoskeletons for Rehabilitation Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Cyberdyne Care Robotics GmbH*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. BIONIK
  • 11.3. ExoAtlet
  • 11.4. Lifeward, Inc.
  • 11.5. Gogoa.eu
  • 11.6. German Bionic Systems GmbH
  • 11.7. Siyi Intelligent Technology Co., Ltd.
  • 11.8. Hocoma
  • 11.9. Rex Bionics Ltd.
  • 11.10. RoboCT

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us